Key Takeaways Mesenchymal stem cells are among the most studied cell types for chronic liver disease, but the approach is still experimental. Researchers think the cells may calm the immune system and slow scar-forming cells, mostly based on lab and animal work. Small human trials reported better survival in some
Key Takeaways Mesenchymal stem cells (MSCs) have been tested in small rheumatoid arthritis (RA) trials, but no trial shows they stop the disease for good. A 2019 study of 64 people with RA reported lower disease scores at one and three years after umbilical cord cell infusion. A 2017 placebo-controlled
Key Takeaways Mesenchymal stem cell (MSC) therapy has been tested in small human trials for chronic lung inflammation, but none show it reverses lung scarring. A 2013 randomized trial of 62 people with chronic obstructive pulmonary disease (COPD) found no lung function gain from infused MSCs. A 2020 randomized trial
